2026 Jonathan R. Pollack: Biology and Biochemistry Researcher – H-Index, Publications & Awards

D-Index & Metrics

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	69	7202	6640	3301	2963	202	47111

Discipline name

D-Index

World Ranking

Current World Ranking

National Ranking

Current National Ranking

Publications

Citations

Biology and Biochemistry

7202

6640

3301

2963

202

47111

Biology and Biochemistry

D-Index

Citations

47111

World Ranking

7202

National Ranking

3301

Overview

Jonathan R. Pollack is affiliated with Stanford University in the United States. Their research spans primarily the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Within these, their notable subfields of study include Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Nutrition and Dietetics, and Hematology.

Their scientific contributions emphasize several main topics of investigation, such as:

Prostate Cancer Treatment and Research
Clinical Nutrition and Gastroenterology
Acute Myeloid Leukemia Research
Ubiquitin and proteasome pathways
Prostate Cancer Diagnosis and Treatment
Urinary Bladder and Prostate Research
Cancer-related molecular mechanisms research

Jonathan R. Pollack's frequent co-authors include:

James D. Brooks (6 co-authored works)
Anna S. Pollack (4 co-authored works)
Robert B. West (4 co-authored works)
Daren K. Heyland (3 co-authored works)
Lucy Wibbenmeyer (3 co-authored works)

Their publications appear regularly in the following venues:

Haematologica (2 publications)
Cancer Research (2 publications)
New England Journal of Medicine (1 publication)
Journal of Dental Research (1 publication)
Journal of Translational Medicine (1 publication)

Selected recent papers by Jonathan R. Pollack include:

A Randomized Trial of Enteral Glutamine for Treatment of Burn Injuries, 2022, New England Journal of Medicine
The retinoic acid receptor co-factor NRIP1 is uniquely upregulated and represents a therapeutic target in acute myeloid leukemia with chromosome 3q rearrangements, 2021, Haematologica
New Ameloblastoma Cell Lines Enable Preclinical Study of Targeted Therapies, 2022, Journal of Dental Research
AZGP1 deficiency promotes angiogenesis in prostate cancer, 2024, Journal of Translational Medicine
Validation of the modified NUTrition Risk Score (mNUTRIC) in mechanically ventilated, severe burn patients: A prospective multinational cohort study, 2021, Burns

Best Publications

Molecular portraits of human breast tumours

Charles M. Perou;Therese Sørlie;Michael B. Eisen;Matt van de Rijn

20711
Citations
Genome-wide analysis of DNA copy-number changes using cDNA microarrays.

Jonathan R. Pollack;Charles M. Perou;Ash A. Alizadeh;Michael B. Eisen

2054
Citations
Gene expression profiling identifies clinically relevant subtypes of prostate cancer

Jacques Lapointe;Chunde Li;John P. Higgins;Matt van de Rijn

1631
Citations
Evolutionary and biomedical insights from the rhesus macaque genome

Richard A. Gibbs;Jeffrey Rogers

1514
Citations
Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors

Jonathan R. Pollack;Therese Sørlie;Charles M. Perou;Christian A. Rees

1476
Citations
Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia.

Lars Bullinger;Konstanze Döhner;Eric Bair;Stefan Fröhling

1240
Citations
The sex-determining region of the human Y chromosome encodes a finger protein

David C. Page;Rebecca Mosher;Elizabeth M. Simpson;Elizabeth M.C. Fisher

1058
Citations
Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery

Jessica Kao;Keyan Salari;Melanie Bocanegra;Yoon-La Choi;Yoon-La Choi

923
Citations
Genome-wide analysis of DNA copy number variation in breast cancer using DNA microarrays

Jonathan R. Pollack;Charles M. Perou;Therese Sorlie;Ash A. Alizadeh

762
Citations
Molecular characterisation of soft tissue tumours: a gene expression study

Torsten O Nielsen;Rob B West;Sabine C Linn;Orly Alter

724
Citations
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer

Anna Bergamaschi;Young H. Kim;Pei Wang;Pei Wang;Therese Sørlie

617
Citations
The spectrum of SWI/SNF mutations, ubiquitous in human cancers.

A. Hunter Shain;Jonathan R. Pollack

591
Citations
Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer

Joseph Amann;Shailaja Kalyankrishna;Pierre P. Massion;Joyce E. Ohm

537
Citations
A transcriptional response to Wnt protein in human embryonic carcinoma cells.

Jennifer Willert;Jennifer Willert;Mirjam Epping;Mirjam Epping;Jonathan R Pollack;Jonathan R Pollack;Patrick O Brown

484
Citations
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a.

Sandrine Sander;Lars Bullinger;Kay Klapproth;Katja Fiedler

472
Citations
Lineage-Specific Gene Duplication and Loss in Human and Great Ape Evolution

Andrew Fortna;Young Kim;Erik MacLaren;Kriste Marshall

354
Citations
Identification of recurrent SMO and BRAF mutations in ameloblastomas

Robert T Sweeney;Andrew C McClary;Benjamin R Myers;Jewison Biscocho

351
Citations
Genomic Profiling Reveals Alternative Genetic Pathways of Prostate Tumorigenesis

Jacques Lapointe;Chunde Li;Craig P. Giacomini;Keyan Salari

348
Citations
A Genome-Wide Screen for Promoter Methylation in Lung Cancer Identifies Novel Methylation Markers for Multiple Malignancies

David S. Shames;Luc Girard;Boning Gao;Mitsuo Sato

321
Citations
GSE12278: MYC stimulates EZH2 expression by repression of its negative regulator miR-26a.

Lars Bullinger;Sandrine Sander;Kay Klapproth;Katja Fiedler

0
Citations